Pub Date : 2023-01-01DOI: 10.1097/j.pbj.0000000000000199
Emídio Vale-Fernandes, Márcia Barreiro, Mariana P Monteiro
Background: Infertility treatments with oocyte donation are becoming frequent. Recruitment of oocyte donors is a demanding and costly process and therefore of crucial importance. The selection of the oocyte donors undergoes a rigorous evaluation process of the candidates with routine measurement of the anti-Müllerian hormone (AMH) levels (ovarian reserve test). Our aim was to assess whether AMH levels could act as a good marker as tool to select the donor candidates and correlate them with the ovarian response to stimulation with a gonadotropin-releasing hormone antagonist protocol as well as to identify and validate the appropriate AMH level threshold by correlating it with the number of oocytes retrieved.
Methods: A retrospective analysis of the oocyte donors' clinical records was performed.
Results: The mean age of the participants was 27 years. The ovarian reserve evaluation showed a mean AMH of 5.20 ng/mL. An average number of 16 oocytes was retrieved (12 mature oocytes MII). AMH levels showed a statistically significant positive correlation with the number of total oocytes retrieved. A threshold value of AMH = 3.2 ng/mL predictive of the retrieval <12 oocytes (areas under the curve, 0.7364; 95% confidence interval: 0.529-0.944) was identified by receiver operating characteristic curve. Using this cutoff, the normal response (12 oocytes) was predicted with a sensitivity of 77% and a specificity of 60%.
Conclusions: The measurement of AMH may be a determining factor in the choice of the oocyte donor candidates to maximize the response to requests from beneficiaries who require donor oocytes to perform assisted reproductive technique cycles.
{"title":"Candidates selection for oocyte donation in a public gamete bank-Predictive value of the anti-Müllerian hormone.","authors":"Emídio Vale-Fernandes, Márcia Barreiro, Mariana P Monteiro","doi":"10.1097/j.pbj.0000000000000199","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000199","url":null,"abstract":"<p><strong>Background: </strong>Infertility treatments with oocyte donation are becoming frequent. Recruitment of oocyte donors is a demanding and costly process and therefore of crucial importance. The selection of the oocyte donors undergoes a rigorous evaluation process of the candidates with routine measurement of the anti-Müllerian hormone (AMH) levels (ovarian reserve test). Our aim was to assess whether AMH levels could act as a good marker as tool to select the donor candidates and correlate them with the ovarian response to stimulation with a gonadotropin-releasing hormone antagonist protocol as well as to identify and validate the appropriate AMH level threshold by correlating it with the number of oocytes retrieved.</p><p><strong>Methods: </strong>A retrospective analysis of the oocyte donors' clinical records was performed.</p><p><strong>Results: </strong>The mean age of the participants was 27 years. The ovarian reserve evaluation showed a mean AMH of 5.20 ng/mL. An average number of 16 oocytes was retrieved (12 mature oocytes MII). AMH levels showed a statistically significant positive correlation with the number of total oocytes retrieved. A threshold value of AMH = 3.2 ng/mL predictive of the retrieval <12 oocytes (areas under the curve, 0.7364; 95% confidence interval: 0.529-0.944) was identified by receiver operating characteristic curve. Using this cutoff, the normal response (12 oocytes) was predicted with a sensitivity of 77% and a specificity of 60%.</p><p><strong>Conclusions: </strong>The measurement of AMH may be a determining factor in the choice of the oocyte donor candidates to maximize the response to requests from beneficiaries who require donor oocytes to perform assisted reproductive technique cycles.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"8 1","pages":"e199"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b8/7c/pj9-8-e199.PMC10194772.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9502279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.1097/j.pbj.0000000000000198
Beatriz Sousa, Ana Grangeia, Joel Pinto, Helena Santos, Sofia Dória
Background: Copy number variations (CNVs) on chromosome 2 are associated with a variety of human diseases particularly neurodevelopmental disorders. Array comparative genomic hybridization (aCGH) constitutes an added value for the diagnosis of neurodevelopmental or neuropsychiatric diseases. This study aims to establish a genotype-phenotype correlation, reporting CNVs on the chromosome 2, contributing for a better characterization of the molecular significance of rare CNVs in this chromosome.
Methods: To accomplish this, a cross-sectional study was performed using genetic information included in a database of the Department of Genetics of the Faculty of Medicine and clinical data from Hospital database. CNVs were classified as pathogenic, benign, variants of unknown significance, and likely pathogenic or likely benign, in accordance with the ACMG Standards and Guidelines.
Results: A total of 2897 patients were studied using aCGH, 32 with CNVs on chromosome 2, 24 classified as likely pathogenic, and 8 as pathogenic. Genomic intervals with a higher incidence were one 2p25.3 and 2q13 regions.
Conclusions: This study will help to establish new genotype-phenotype correlations, allowing update of databases and literature and the improvement of diagnosis and genetic counseling which could be an added value for prenatal genetic counseling.
{"title":"Copy number variations on chromosome 2: impact on human phenotype, a cross-sectional study.","authors":"Beatriz Sousa, Ana Grangeia, Joel Pinto, Helena Santos, Sofia Dória","doi":"10.1097/j.pbj.0000000000000198","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000198","url":null,"abstract":"<p><strong>Background: </strong>Copy number variations (CNVs) on chromosome 2 are associated with a variety of human diseases particularly neurodevelopmental disorders. Array comparative genomic hybridization (aCGH) constitutes an added value for the diagnosis of neurodevelopmental or neuropsychiatric diseases. This study aims to establish a genotype-phenotype correlation, reporting CNVs on the chromosome 2, contributing for a better characterization of the molecular significance of rare CNVs in this chromosome.</p><p><strong>Methods: </strong>To accomplish this, a cross-sectional study was performed using genetic information included in a database of the Department of Genetics of the Faculty of Medicine and clinical data from Hospital database. CNVs were classified as pathogenic, benign, variants of unknown significance, and likely pathogenic or likely benign, in accordance with the ACMG Standards and Guidelines.</p><p><strong>Results: </strong>A total of 2897 patients were studied using aCGH, 32 with CNVs on chromosome 2, 24 classified as likely pathogenic, and 8 as pathogenic. Genomic intervals with a higher incidence were one 2p25.3 and 2q13 regions.</p><p><strong>Conclusions: </strong>This study will help to establish new genotype-phenotype correlations, allowing update of databases and literature and the improvement of diagnosis and genetic counseling which could be an added value for prenatal genetic counseling.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"8 1","pages":"e198"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ec/b3/pj9-8-e198.PMC10194716.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9873576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1097/j.pbj.0000000000000168
Isabel Rodrigues, André Laranja, Luísa Carvalho, Lurdes Salgado
Endometrial cancer is a common malignancy of the female reproductive system. Most are early-stage but can spread locally and metastize (also to the vaginal wall). We report 2 clinical cases of post-menopausal women with early-stage endometrial cancer, after hysterectomy, who were offered adjuvant brachytherapy as monotherapy according to pathological stage and histology. On gynecological examination before brachytherapy, a vaginal nodule was identified in both patients, clinically compatible with a metastatic lesion. However, a biopsy was requested and histology classified both lesions as vaginal leiomyomas. The patients then proceeded with their initial strategy. It is therefore imperative to obtain histological confirmation of any new finding that may restage and alter the planned adjuvant treatment, to better adjust treatment to the correct stage, predict prognosis, and avoid iatrogeny. In this article, we highlight the importance of a thorough differential diagnosis and biopsy confirmation of any vaginal lesion that may change the adjuvant management of an early-stage endometrial tumor, and review published literature on vaginal leiomyomas.
{"title":"Stage I endometrial adenocarcinoma with a vaginal nodule-the importance of differential diagnosis.","authors":"Isabel Rodrigues, André Laranja, Luísa Carvalho, Lurdes Salgado","doi":"10.1097/j.pbj.0000000000000168","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000168","url":null,"abstract":"Endometrial cancer is a common malignancy of the female reproductive system. Most are early-stage but can spread locally and metastize (also to the vaginal wall). We report 2 clinical cases of post-menopausal women with early-stage endometrial cancer, after hysterectomy, who were offered adjuvant brachytherapy as monotherapy according to pathological stage and histology. On gynecological examination before brachytherapy, a vaginal nodule was identified in both patients, clinically compatible with a metastatic lesion. However, a biopsy was requested and histology classified both lesions as vaginal leiomyomas. The patients then proceeded with their initial strategy. It is therefore imperative to obtain histological confirmation of any new finding that may restage and alter the planned adjuvant treatment, to better adjust treatment to the correct stage, predict prognosis, and avoid iatrogeny. In this article, we highlight the importance of a thorough differential diagnosis and biopsy confirmation of any vaginal lesion that may change the adjuvant management of an early-stage endometrial tumor, and review published literature on vaginal leiomyomas.","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"7 6","pages":"e168"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158858/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9430257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1097/j.pbj.0000000000000195
Sara Marote, Joana Marinho, Maria Cândida Silva, José Ferraz Gonçalves
Background: Anemia is highly prevalent in patients with advanced cancer and adversely affects the quality of life. There are limited data on the frequency, clinical utility, and effectiveness of red blood cell (RBC) transfusions, and no randomized controlled clinical trials or clinical practice guidelines are available. The aim of this study was to evaluate clinician practices on RBC transfusion in an oncologic palliative care service and its impact on patients' symptoms, adverse events, and overall survival.
Methods: This is a retrospective analysis of all patients with advanced cancer who received RBC transfusions admitted for 3 years. Preblood counts, the reason for transfusion, subjective benefit, and objective outcomes were listed.
Results: We identified 179 patients who underwent RBC transfusions. The mean age was 67 years, and 60% were male. We found a total of 435 RBC units in 301 transfusion episodes. Asthenia/fatigue was the most frequent symptom (68%). The mean pretransfusion hemoglobin (Hb) was 6.85 g/dL, and 48% of patients had a Hb above 7 g/dL. The symptomatic benefit was achieved in 36% of patients. Adverse events were reported in 4%, with a 30-day survival rate of 57%. A statistically significant association was found between Eastern Cooperative Oncology Group performance status (ECOG-PS) and the symptomatic benefit (P = .005). Hb level pretransfusion, ECOG-PS, and symptomatic benefits with transfusions were significantly associated with survival.
Conclusion: This study suggests that patients with advanced cancer with a higher functioning level may benefit more from RBC transfusion. Post-transfusion symptomatic benefits and pretransfusion ECOG-PS and Hb levels are independent predictors of survival. Further studies are needed to develop validated measures of objective functional changes to evaluate transfusions' clinical impact and identify patients most likely to benefit from it.
{"title":"Transfusion practices in patients with advanced cancer: a retrospective study in a palliative care service.","authors":"Sara Marote, Joana Marinho, Maria Cândida Silva, José Ferraz Gonçalves","doi":"10.1097/j.pbj.0000000000000195","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000195","url":null,"abstract":"<p><strong>Background: </strong>Anemia is highly prevalent in patients with advanced cancer and adversely affects the quality of life. There are limited data on the frequency, clinical utility, and effectiveness of red blood cell (RBC) transfusions, and no randomized controlled clinical trials or clinical practice guidelines are available. The aim of this study was to evaluate clinician practices on RBC transfusion in an oncologic palliative care service and its impact on patients' symptoms, adverse events, and overall survival.</p><p><strong>Methods: </strong>This is a retrospective analysis of all patients with advanced cancer who received RBC transfusions admitted for 3 years. Preblood counts, the reason for transfusion, subjective benefit, and objective outcomes were listed.</p><p><strong>Results: </strong>We identified 179 patients who underwent RBC transfusions. The mean age was 67 years, and 60% were male. We found a total of 435 RBC units in 301 transfusion episodes. Asthenia/fatigue was the most frequent symptom (68%). The mean pretransfusion hemoglobin (Hb) was 6.85 g/dL, and 48% of patients had a Hb above 7 g/dL. The symptomatic benefit was achieved in 36% of patients. Adverse events were reported in 4%, with a 30-day survival rate of 57%. A statistically significant association was found between Eastern Cooperative Oncology Group performance status (ECOG-PS) and the symptomatic benefit (<i>P</i> = .005). Hb level pretransfusion, ECOG-PS, and symptomatic benefits with transfusions were significantly associated with survival.</p><p><strong>Conclusion: </strong>This study suggests that patients with advanced cancer with a higher functioning level may benefit more from RBC transfusion. Post-transfusion symptomatic benefits and pretransfusion ECOG-PS and Hb levels are independent predictors of survival. Further studies are needed to develop validated measures of objective functional changes to evaluate transfusions' clinical impact and identify patients most likely to benefit from it.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"7 6","pages":"e195"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3d/6e/pj9-7-e195.PMC10158856.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9430259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1097/j.pbj.0000000000000186
David Peres, Paulo Figueiredo, Paulo Andrade, Nuno Rocha-Pereira, Cláudia Carvalho, Rita Ferraz, Raquel Duro, Arnaldo Dias, Abel Gomes, Cláudia Pereira, Gisélia Braga, Virginia Pereira, Lino Azevedo, Edgar Moniz, Manuela Ribeiro, Eugénia Ferreira, Vera Manageiro, José Teixeira, Tiago Guimarães, Manuela Caniça, Carlos Alves
Background: KPC-producing K pneumoniae (KPC-Kp) is a public health problem with important clinical and epidemiological implications. We describe an outbreak of KPC-Kp at vascular surgery and neurosurgery wards in a central hospital in Porto, Portugal.
Methods: A case of KPC-Kp was considered to be a patient positive for KPC-Kp with strong epidemiological plausibility of having acquired this microorganism in the affected wards and/or with genetic relationship ≥92% between KPC-Kp isolates. Active surveillance cultures (ASCs) and real-time polymerase chain reaction were used for the detection of carbapenemase genes through rectal swab in a selected population. Molecular analysis was performed using pulsed-field gel electrophoresis at the National Reference Laboratory. Patient risk factors were collected from the electronic medical record system. Information regarding outbreak containment strategy was collected from the Infection Control Unit records.
Results: Of the 16 cases, 11 (69%) were identified through active screening, representing 1.4% of the total 766 ASCs collected. The most frequent risk factors identified were previous admission (63%), antibiotic exposure in the past 6 months (50%), and immunodepression (44%). The length of stay until KPC-Kp detection was high (0-121 days, mean 35.6), as was the total length of stay (5-173 days, mean 56.6). Three patients (19%) were infected by KPC-Kp, 2 of whom died. One previously colonized patient died later because of KPC-Kp infection.
Conclusions: Multifactorial strategy based on contact precautions (with patient and healthcare professional cohorts) and ASC, as well as Antibiotic Stewardship Program reinforcement, allowed to contain this KPC-Kp outbreak.
{"title":"Outbreak of KPC-producing <i>Klebsiella pneumoniae</i> at a Portuguese university hospital: Epidemiological characterization and containment measures.","authors":"David Peres, Paulo Figueiredo, Paulo Andrade, Nuno Rocha-Pereira, Cláudia Carvalho, Rita Ferraz, Raquel Duro, Arnaldo Dias, Abel Gomes, Cláudia Pereira, Gisélia Braga, Virginia Pereira, Lino Azevedo, Edgar Moniz, Manuela Ribeiro, Eugénia Ferreira, Vera Manageiro, José Teixeira, Tiago Guimarães, Manuela Caniça, Carlos Alves","doi":"10.1097/j.pbj.0000000000000186","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000186","url":null,"abstract":"<p><strong>Background: </strong>KPC-producing <i>K pneumoniae</i> (KPC-Kp) is a public health problem with important clinical and epidemiological implications. We describe an outbreak of KPC-Kp at vascular surgery and neurosurgery wards in a central hospital in Porto, Portugal.</p><p><strong>Methods: </strong>A case of KPC-Kp was considered to be a patient positive for KPC-Kp with strong epidemiological plausibility of having acquired this microorganism in the affected wards and/or with genetic relationship ≥92% between KPC-Kp isolates. Active surveillance cultures (ASCs) and real-time polymerase chain reaction were used for the detection of carbapenemase genes through rectal swab in a selected population. Molecular analysis was performed using pulsed-field gel electrophoresis at the National Reference Laboratory. Patient risk factors were collected from the electronic medical record system. Information regarding outbreak containment strategy was collected from the Infection Control Unit records.</p><p><strong>Results: </strong>Of the 16 cases, 11 (69%) were identified through active screening, representing 1.4% of the total 766 ASCs collected. The most frequent risk factors identified were previous admission (63%), antibiotic exposure in the past 6 months (50%), and immunodepression (44%). The length of stay until KPC-Kp detection was high (0-121 days, mean 35.6), as was the total length of stay (5-173 days, mean 56.6). Three patients (19%) were infected by KPC-Kp, 2 of whom died. One previously colonized patient died later because of KPC-Kp infection.</p><p><strong>Conclusions: </strong>Multifactorial strategy based on contact precautions (with patient and healthcare professional cohorts) and ASC, as well as Antibiotic Stewardship Program reinforcement, allowed to contain this KPC-Kp outbreak.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"7 6","pages":"e186"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9435511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1097/j.pbj.0000000000000188
Helga A S Afonso, Mariana V Farraia, Mónica A Vieira, João Cavaleiro Rufo
Currently available urinalysis methods are often applied for screening and monitoring of several pathologies. However, traditionally analyzed biomarkers in urinalysis still lack sensitivity and specificity to accurately diagnose some diseases. Several studies have proposed the use of electronic noses (eNoses) for the analysis of volatile organic compounds in urine samples that may, directly or indirectly, correlate with certain pathologies. Hence, the aim of this study was to perform a systematic review and meta-analysis of studies concerning the use of portable electronic noses for diagnosis or monitoring of pathologies through analysis of urine samples. A systematic review of the literature was held according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Twenty-four articles met the inclusion criteria and were included in the analysis. The results of the revised studies showed that there are various volatile organic compound profiles, identified through eNose analysis, that may be applied for diagnosis or monitoring of several diseases, such as diabetes, urinary tract infection, inflammatory bowel disease, and kidney disease. A meta-analysis was conducted taking into consideration the data of 10 of the initial 24 articles. The pooled sensitivity, specificity, and diagnostic odds ratio were 84% (95% CI, 0.72-0.92), 85% (95% CI, 0.75-0.91), and 24.17 (95% CI: 7.85-74.41), respectively. The area under the receiver operating characteristic curve was 0.897. These results suggest that eNose technology has adequate diagnostic accuracy for several pathologies and could be a promising screening tool for clinical settings. However, more studies are needed to reduce heterogeneity between results.
{"title":"Diagnosis of pathological conditions through electronic nose analysis of urine samples: a systematic review and meta-analysis.","authors":"Helga A S Afonso, Mariana V Farraia, Mónica A Vieira, João Cavaleiro Rufo","doi":"10.1097/j.pbj.0000000000000188","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000188","url":null,"abstract":"<p><p>Currently available urinalysis methods are often applied for screening and monitoring of several pathologies. However, traditionally analyzed biomarkers in urinalysis still lack sensitivity and specificity to accurately diagnose some diseases. Several studies have proposed the use of electronic noses (eNoses) for the analysis of volatile organic compounds in urine samples that may, directly or indirectly, correlate with certain pathologies. Hence, the aim of this study was to perform a systematic review and meta-analysis of studies concerning the use of portable electronic noses for diagnosis or monitoring of pathologies through analysis of urine samples. A systematic review of the literature was held according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Twenty-four articles met the inclusion criteria and were included in the analysis. The results of the revised studies showed that there are various volatile organic compound profiles, identified through eNose analysis, that may be applied for diagnosis or monitoring of several diseases, such as diabetes, urinary tract infection, inflammatory bowel disease, and kidney disease. A meta-analysis was conducted taking into consideration the data of 10 of the initial 24 articles. The pooled sensitivity, specificity, and diagnostic odds ratio were 84% (95% CI, 0.72-0.92), 85% (95% CI, 0.75-0.91), and 24.17 (95% CI: 7.85-74.41), respectively. The area under the receiver operating characteristic curve was 0.897. These results suggest that eNose technology has adequate diagnostic accuracy for several pathologies and could be a promising screening tool for clinical settings. However, more studies are needed to reduce heterogeneity between results.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"7 6","pages":"e188"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/6b/pj9-7-e188.PMC10158878.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9798964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1097/j.pbj.0000000000000197
Catarina Cidade-Rodrigues, Filipe M Cunha, Catarina Elias, Marta Carreira, Isaac Barroso, Paulo Bettencourt, Patrícia Lourenço
Background: Hypermagnesemia predicts mortality in chronic heart failure (HF); however, in acute HF, magnesium does not seem to be outcome-associated. Diabetes mellitus (DM) frequently associates with altered magnesium status. We hypothesized that DM might influence the prognostic impact of magnesium in acute HF.
Methods: This is a retrospective cohort study of hospitalized patients with acute HF. Patients without data on admission serum magnesium were excluded. Follow-up: 1 year from hospital admission. Primary end point: all-cause mortality. Patients were divided according to median serum magnesium (1.64 mEq/L). The Kaplan-Meier survival method was used to determine survival curves according to magnesium levels. The analysis was stratified according to the presence of DM. A multivariable Cox regression analysis was used to study the prognostic impact of magnesium.
Results: We studied 606 patients. The mean age was 76 ± 12 years, 44.1% were male, 50.7% had DM, and 232 (38.3%) died during follow-up. Median magnesium was 1.64 (1.48-1.79) mEq/L. Patients with magnesium ≥1.64 mEq/L had higher 1-year mortality [141 (46.4%) vs 91 (30.1%), P < .001]. After adjustments for age, sex, history of atrial fibrillation, systolic blood pressure, heart rate, ischemic etiology, B-type natriuretic peptide, estimated glomerular filtration rate, alcohol consumption, antihyperglycaemic agents or glycated hemoglobin, admission glycemia, New York Heart Association class IV, and severe left ventricle systolic dysfunction, serum magnesium ≥1.64 mEq/L was associated with higher mortality only in patients with DM: HR 1.89 (95% confidence interval: 1.19-3.00), P = .007, and 1.27 (95% confidence interval: 0.83-1.94) and P = .26 for non-DM patients. The results were similar if magnesium was analyzed as a continuous variable. Per 0.1 mEq/L increase in magnesium levels, patients with DM had 13% increased risk of 1-year mortality.
Conclusions: Higher magnesium levels were associated with worse prognosis only in HF patients with DM.
背景:高镁血症可预测慢性心力衰竭(HF)患者的死亡率;然而,在急性心衰中,镁似乎与结果无关。糖尿病(DM)常与镁状态改变有关。我们假设糖尿病可能影响镁对急性心衰患者预后的影响。方法:对急性心衰住院患者进行回顾性队列研究。没有入院血清镁数据的患者被排除在外。随访:入院后1年。主要终点:全因死亡率。根据血清镁中位数(1.64 mEq/L)进行分组。采用Kaplan-Meier生存法根据镁水平确定生存曲线。根据DM的存在进行分层分析。采用多变量Cox回归分析研究镁对预后的影响。结果:我们研究了606例患者。平均年龄76±12岁,男性44.1%,糖尿病50.7%,随访期间死亡232例(38.3%)。镁的中位数为1.64 (1.48-1.79)mEq/L。镁≥1.64 mEq/L的患者1年死亡率更高[141 (46.4%)vs 91 (30.1%), P < 0.001]。在调整了年龄、性别、房颤史、收缩压、心率、缺血性病因、b型利钠肽、肾小球滤过率、酒精摄入量、抗高血糖药物或糖化血红蛋白、入院血糖、纽约心脏协会IV级和严重左心室收缩功能障碍等因素后,血清镁≥1.64 mEq/L仅与DM患者的高死亡率相关:HR 1.89(95%可信区间:1.19-3.00), P = 0.007,非糖尿病患者P = 1.27(95%可信区间:0.83-1.94),P = 0.26。如果把镁作为一个连续变量来分析,结果是相似的。镁水平每增加0.1 mEq/L,糖尿病患者1年死亡率增加13%。结论:高镁水平仅与HF合并DM患者的预后差相关。
{"title":"The prognostic impact of magnesium in acute heart failure is different according to the presence of diabetes mellitus.","authors":"Catarina Cidade-Rodrigues, Filipe M Cunha, Catarina Elias, Marta Carreira, Isaac Barroso, Paulo Bettencourt, Patrícia Lourenço","doi":"10.1097/j.pbj.0000000000000197","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000197","url":null,"abstract":"<p><strong>Background: </strong>Hypermagnesemia predicts mortality in chronic heart failure (HF); however, in acute HF, magnesium does not seem to be outcome-associated. Diabetes mellitus (DM) frequently associates with altered magnesium status. We hypothesized that DM might influence the prognostic impact of magnesium in acute HF.</p><p><strong>Methods: </strong>This is a retrospective cohort study of hospitalized patients with acute HF. Patients without data on admission serum magnesium were excluded. Follow-up: 1 year from hospital admission. Primary end point: all-cause mortality. Patients were divided according to median serum magnesium (1.64 mEq/L). The Kaplan-Meier survival method was used to determine survival curves according to magnesium levels. The analysis was stratified according to the presence of DM. A multivariable Cox regression analysis was used to study the prognostic impact of magnesium.</p><p><strong>Results: </strong>We studied 606 patients. The mean age was 76 ± 12 years, 44.1% were male, 50.7% had DM, and 232 (38.3%) died during follow-up. Median magnesium was 1.64 (1.48-1.79) mEq/L. Patients with magnesium ≥1.64 mEq/L had higher 1-year mortality [141 (46.4%) vs 91 (30.1%), <i>P</i> < .001]. After adjustments for age, sex, history of atrial fibrillation, systolic blood pressure, heart rate, ischemic etiology, B-type natriuretic peptide, estimated glomerular filtration rate, alcohol consumption, antihyperglycaemic agents or glycated hemoglobin, admission glycemia, New York Heart Association class IV, and severe left ventricle systolic dysfunction, serum magnesium ≥1.64 mEq/L was associated with higher mortality only in patients with DM: HR 1.89 (95% confidence interval: 1.19-3.00), <i>P</i> = .007, and 1.27 (95% confidence interval: 0.83-1.94) and <i>P</i> = .26 for non-DM patients. The results were similar if magnesium was analyzed as a continuous variable. Per 0.1 mEq/L increase in magnesium levels, patients with DM had 13% increased risk of 1-year mortality.</p><p><strong>Conclusions: </strong>Higher magnesium levels were associated with worse prognosis only in HF patients with DM.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"7 6","pages":"e197"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a1/9d/pj9-7-e197.PMC10158881.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9423056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1097/j.pbj.0000000000000196
Maria Leonor Moura, Sónia Martins, Raquel Correia, Elika Pinho, Cristiana Paulo, Maria João Silva, Ana Teixeira, Liliana Fontes, Luís Lopes, José Artur Paiva, Luís Filipe Azevedo, Lia Fernandes
Background: Delirium is a very common neuropsychiatric disorder in the elderly, with a significant physical and psychological burden. Much is still unknown about its psychological effects. This study aims to identify the proportion of patients who recall delirium and to analyze the distress caused by it. In addition, this study aims to analyze the association between delirium recall and related distress and global psychological distress regarding hospitalization. Methods: This is a prospective study with elderly hospitalized patients in level-2 units of intensive care medicine department of a university hospital. Exclusion criteria were a Glasgow Coma Scale total ≤11, brain injury, blindness, deafness, or inability to communicate. Delirium was daily assessed with the Confusion Assessment Method. Delirium recall and related distress in patients were measured using the Delirium Experience Questionnaire. Global psychological distress was assessed with the Kessler Psychological Distress Scale. Results: From 105 patients, 38 (36.2%) developed delirium. Most patients did not remember the delirium episode (64.7%). Among those who remembered (35.3%), most described delirium as a distressing experience (75%). Delirium recall was associated with high global psychological distress (P = .029).Conclusions: Distress related to delirium is high, namely in patients who recall the episode. Global psychological distress during hospitalization is associated with delirium recall. This study highlights the need to assess the experience of delirium in these patients, as well as the importance of providing support and psychological interventions to minimize the associated distress.
{"title":"Recall of delirium and related distress in elderly hospitalized patients: A prospective study.","authors":"Maria Leonor Moura, Sónia Martins, Raquel Correia, Elika Pinho, Cristiana Paulo, Maria João Silva, Ana Teixeira, Liliana Fontes, Luís Lopes, José Artur Paiva, Luís Filipe Azevedo, Lia Fernandes","doi":"10.1097/j.pbj.0000000000000196","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000196","url":null,"abstract":"<p><p><b>Background:</b> Delirium is a very common neuropsychiatric disorder in the elderly, with a significant physical and psychological burden. Much is still unknown about its psychological effects. This study aims to identify the proportion of patients who recall delirium and to analyze the distress caused by it. In addition, this study aims to analyze the association between delirium recall and related distress and global psychological distress regarding hospitalization. <b>Methods:</b> This is a prospective study with elderly hospitalized patients in level-2 units of intensive care medicine department of a university hospital. Exclusion criteria were a Glasgow Coma Scale total ≤11, brain injury, blindness, deafness, or inability to communicate. Delirium was daily assessed with the Confusion Assessment Method. Delirium recall and related distress in patients were measured using the Delirium Experience Questionnaire. Global psychological distress was assessed with the Kessler Psychological Distress Scale. <b>Results:</b> From 105 patients, 38 (36.2%) developed delirium. Most patients did not remember the delirium episode (64.7%). Among those who remembered (35.3%), most described delirium as a distressing experience (75%). Delirium recall was associated with high global psychological distress (<i>P</i> = .029)<i>.</i> <b>Conclusions:</b> Distress related to delirium is high, namely in patients who recall the episode. Global psychological distress during hospitalization is associated with delirium recall. This study highlights the need to assess the experience of delirium in these patients, as well as the importance of providing support and psychological interventions to minimize the associated distress.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"7 6","pages":"e196"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/36/60/pj9-7-e196.PMC10158885.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9798963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1097/j.pbj.0000000000000180
Telma Fonseca, Mariana Coimbra, Hugo Santos-Sousa, Elisabete Barbosa, José Barbosa
Background: Perioperative chemotherapy (PeriCh) is the current standard of care for stage II/III gastric cancer tumors in Europe. However, when it concerns patients who endure complications during PeriCh it is unclear if it increases the risk of postoperative complications and other poorer surgical outcomes. We aim to demonstrate if there is an association between having complications during PeriCh and postoperative complications and histopathological response.
Methods: We conducted a retrospective, transversal, and observational study, including all patients with diagnosed gastric cancer who underwent PeriCh followed by surgical resection during the period of eight years.
Results: We included 80 patients with a median age of 64.0years (min 24, max 78). Eighty-eight-point eight percent ended the chemotherapy regime proposed, with a median duration of 42 days, and were also submitted to gastric resection: 58.8% total gastrectomy and 41.2% distal gastrectomy. Twelve-point five percent of the patients had no complications during the PeriCh period and 16.3% had >2 complications. Twenty-five percent of patients had a histological response of <10% of tumor burden, but in 41.3% only regression of <50% could be obtained. No significant association was found between complications during PeriCh and adverse surgical outcomes (P = .497). Patients with complications during PeriCh had slightly higher median time difference from end of PeriCh until surgery, but with no statistical significance (P = .575).
Conclusions: In our sample, the existence of association between complications during PeriCh and postoperative complications or histological response was not demonstrated.
{"title":"Impact of perioperative chemotherapy in the treatment of patients with gastric cancer.","authors":"Telma Fonseca, Mariana Coimbra, Hugo Santos-Sousa, Elisabete Barbosa, José Barbosa","doi":"10.1097/j.pbj.0000000000000180","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000180","url":null,"abstract":"<p><strong>Background: </strong>Perioperative chemotherapy (PeriCh) is the current standard of care for stage II/III gastric cancer tumors in Europe. However, when it concerns patients who endure complications during PeriCh it is unclear if it increases the risk of postoperative complications and other poorer surgical outcomes. We aim to demonstrate if there is an association between having complications during PeriCh and postoperative complications and histopathological response.</p><p><strong>Methods: </strong>We conducted a retrospective, transversal, and observational study, including all patients with diagnosed gastric cancer who underwent PeriCh followed by surgical resection during the period of eight years.</p><p><strong>Results: </strong>We included 80 patients with a median age of 64.0years (min 24, max 78). Eighty-eight-point eight percent ended the chemotherapy regime proposed, with a median duration of 42 days, and were also submitted to gastric resection: 58.8% total gastrectomy and 41.2% distal gastrectomy. Twelve-point five percent of the patients had no complications during the PeriCh period and 16.3% had >2 complications. Twenty-five percent of patients had a histological response of <10% of tumor burden, but in 41.3% only regression of <50% could be obtained. No significant association was found between complications during PeriCh and adverse surgical outcomes (<i>P</i> = .497). Patients with complications during PeriCh had slightly higher median time difference from end of PeriCh until surgery, but with no statistical significance (<i>P</i> = .575).</p><p><strong>Conclusions: </strong>In our sample, the existence of association between complications during PeriCh and postoperative complications or histological response was not demonstrated.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"7 6","pages":"e180"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1a/bf/pj9-7-e180.PMC10158857.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9798960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1097/j.pbj.0000000000000178
Andreia Maria Novo Lima, Maria Manuela Ferreira da Silva Martins, Maria Salomé Martins Ferreira, Carla Sílvia Fernandes, Soraia Dornelles Schoeller, Adriana Raquel Neves Coelho, Vítor Sérgio Oliveira Parola
Background: The concept of autonomy is composed of several components, making it a multidimensional concept. This includes cognitive ability, intellectual ability, emotional intelligence, social situation, and physical ability skills. This study aimed to describe the experiences attributed to the meaning of the concept of autonomy, by specialist nurses. Methods: A descriptive phenomenological study was carried out, according to the Giorgi method. Eighteen nurses were recruited at a hospital in Portugal. Data were collected through individual interviews. Results: The 18 specialist nurses work on average as nurses for 16years and are specialist nurses; for an average of 5.9years, most are specialist nurses in rehabilitation nursing. From the data analysis, six themes emerged: ability to do, ability to resolve, decision ability, cognitive ability, social integration, and emotional intelligence. Conclusions: Most professionals perceive the concept as the ability to perform activities of daily living and the ability to make decisions, especially concerning informed consent. It is necessary to raise awareness of the breadth of this concept since the quality of life and dignity of the elderly person depends on autonomy.
{"title":"Concept of older person autonomy: phenomenological study of the opinion of specialist nurses.","authors":"Andreia Maria Novo Lima, Maria Manuela Ferreira da Silva Martins, Maria Salomé Martins Ferreira, Carla Sílvia Fernandes, Soraia Dornelles Schoeller, Adriana Raquel Neves Coelho, Vítor Sérgio Oliveira Parola","doi":"10.1097/j.pbj.0000000000000178","DOIUrl":"https://doi.org/10.1097/j.pbj.0000000000000178","url":null,"abstract":"<p><p><b>Background:</b> The concept of autonomy is composed of several components, making it a multidimensional concept. This includes cognitive ability, intellectual ability, emotional intelligence, social situation, and physical ability skills. This study aimed to describe the experiences attributed to the meaning of the concept of autonomy, by specialist nurses. <b>Methods:</b> A descriptive phenomenological study was carried out, according to the Giorgi method. Eighteen nurses were recruited at a hospital in Portugal. Data were collected through individual interviews. <b>Results:</b> The 18 specialist nurses work on average as nurses for 16years and are specialist nurses; for an average of 5.9years, most are specialist nurses in rehabilitation nursing. From the data analysis, six themes emerged: ability to do, ability to resolve, decision ability, cognitive ability, social integration, and emotional intelligence. <b>Conclusions:</b> Most professionals perceive the concept as the ability to perform activities of daily living and the ability to make decisions, especially concerning informed consent. It is necessary to raise awareness of the breadth of this concept since the quality of life and dignity of the elderly person depends on autonomy.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":"7 6","pages":"e178"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9430263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}